New Paper Alert
Eliezer Van Allen: New Insights Into Chemotherapy Resistance in Bladder Cancer
Eliezer Van Allen/blog.dana-farber.org

Eliezer Van Allen: New Insights Into Chemotherapy Resistance in Bladder Cancer

Eliezer Van Allen, Chandra Nohria Family Chair for AI in Cancer Research at Dana-Farber Cancer Institute, Professor of Medicine at Harvard Medical School, shared on LinkedIn:

”In our latest, we studied how certain immune cells surround bladder tumors and contribute to chemotherapy resistance, pointing to a surprising potential therapeutic target – congrats Filipe Carvalho et al!”

Title: Tumor-myeloid crosstalk drives therapy resistance in localized bladder cancer

Authors: Filipe L.F. Carvalho, Jihyun Lee, Nikolaos Kalavros, Yuzhen Zhou, Daniel Michaud, Isabella Stelter, Hiba Siddiqui, Konrad Stawiski, Ramya Ravindranathan, Julia Perera, Shuoshuo Wang, Breanna Titchen, Amanda Garza, Kevin Bi, Jihye Park, Elinor G. Sterner, Jillian M. Egan, Yuna Hirohashi, Raie T. Bekele, Ilana Epstein, Ioannis Vlachos, Li Jia, Adam S. Kibel, Michelle Hirsch, Joaquim Bellmunt, Jennifer L. Guerriero, Kent W. Mouw, Eliezer M. Van Allen

Read the full article.

Eliezer Van Allen: New Insights Into Chemotherapy Resistance in Bladder Cancer

Other articles featuring Eliezer Van Allen on OncoDaily.

Adam S. Kibel Amanda Garza Bladder Tumor Breanna Titchen cancer Daniel Michaud Eliezer M Van Allen Eliezer Van Allen Elinor G. Sterner Filipe Carvalho Filipe L.F. Carvalho Hiba Siddiqui Ilana Epstein Ioannis Vlachos Isabella Stelter Jennifer L. Guerriero Jihye Park Jihyun Lee Jillian M. Egan Joaquim Bellmunt Julia Perera Kent W. Mouw Kevin Bi Konrad Stawiski Li Jia Michelle Hirsch Nikolaos Kalavros OncoDaily Oncology Raie T. Bekele Ramya Ravindranathan Shuoshuo Wang Yuna Hirohashi Yuzhen Zhou